Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - RESEARCH & DEVELOPMENT
Research & Development URGN - UroGen Pharma Ltd.
45.6 M
LAST VALUE
-2.15%
2 YEAR CAGR
4.31%
5 YEAR CAGR
34.62%
10 YEAR CAGR